This protocol is judged by an institutional review board, an independent team that assessments any clinical trials involving human beings. If a research will involve a Plan I drug, once the board approves the protocol as ethical, the scientists have to apply for an investigational new drug (IND) number through the FDA.And since the copyright is goi… Read More